This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Reymond, D.
Right arrow Articles by Spika, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Reymond, D.
Right arrow Articles by Spika, J.

Next Article 

Journal of Clinical Microbiology, Sep 1996, 2053-2057, Vol 34, No. 9
Copyright © 1996 by the American Society for Microbiology. All rights reserved.

Neutralizing antibodies to Escherichia coli Vero cytotoxin 1 and antibodies to O157 lipopolysaccharide in healthy farm family members and urban residents

D Reymond, RP Johnson, MA Karmali, M Petric, M Winkler, S Johnson, K Rahn, S Renwick, J Wilson, RC Clarke and J Spika
Research Institute, Hospital for Sick Children, Toronto, Ontario, Canada.

An enzyme-linked immunosorbent assay (ELISA) to detect antibodies to Escherichia coli O157 lipopolysaccharide (LPS) was developed with sera from 63 children with confirmed recent E. coli O157 infection and from 256 age-stratified urban controls. The median ELISA values for control and case sera were 0.05 (interquartile range, 0 to 0.20; mean +/- standard deviation [SD], 0.15 +/- 0.22) and 1.41 (interquartile range, 1.11 to 1.59; mean +/- SD, 1.41 +/- 0.53), respectively (P < 0.001). With a breakpoint of 0.59 (mean ELISA value of the control sera + 2 SDs), the assay had a sensitivity, specificity, and positive and negative predictive values of 95, 94, 80, and 98%, respectively, for recent E. coli O157 infection. The O157 LPS assay and Vero cytotoxin (VT) 1-neutralizing-antibody (NAb) assay were used to compare the relative frequencies of O157 LPS antibodies and VT1-NAbs in an age- stratified urban population from Toronto, Ontario, Canada, and in 216 healthy family members from dairy farm in southern Ontario. The frequency of O157 LPS antibodies was about threefold higher in dairy farm residents (12.5%) than in urban residents (4.7%) (P < 0.01). Similarly, the frequency of VT1-NAbs was about sixfold higher in dairy farm residents (42.0%) than in urban residents (7.7%) (P < 0.001). These findings are consistent with a greater level of exposure of dairy farm residents to VT-producing E. coli (VTEC) strains. The high rate of seropositivity to VT1 in farm residents probably reflects the booster effect of repeated VTEC exposures and argues against a sustained generalized immunosuppressive effect of VT1. Seroepidemiological studies may help in assessing the level of exposure of different populations to VTEC strains.


This article has been cited by other articles:

  • Varma, J. K., Greene, K. D., Reller, M. E., DeLong, S. M., Trottier, J., Nowicki, S. F., DiOrio, M., Koch, E. M., Bannerman, T. L., York, S. T., Lambert-Fair, M.-A., Wells, J. G., Mead, P. S. (2003). An Outbreak of Escherichia coli O157 Infection Following Exposure to a Contaminated Building. JAMA 290: 2709-2712 [Abstract] [Full Text]  
  • Navarro, A., Eslava, C., Hernandez, U., Navarro-Henze, J. L., Aviles, M., Garcia-de la Torre, G., Cravioto, A. (2003). Antibody Responses to Escherichia coli O157 and Other Lipopolysaccharides in Healthy Children and Adults. CVI 10: 797-801 [Abstract] [Full Text]  
  • Crump, J. A., Sulka, A. C., Langer, A. J., Schaben, C., Crielly, A. S., Gage, R., Baysinger, M., Moll, M., Withers, G., Toney, D. M., Hunter, S. B., Hoekstra, R. M., Wong, S. K., Griffin, P. M., Van Gilder, T. J. (2002). An Outbreak of Escherichia coli O157:H7 Infections among Visitors to a Dairy Farm. NEJM 347: 555-560 [Abstract] [Full Text]  
  • Ludwig, K., Sarkim, V., Bitzan, M., Karmali, M. A., Bobrowski, C., Ruder, H., Laufs, R., Sobottka, I., Petric, M., Karch, H., Muller-Wiefel, D. E. (2002). Shiga Toxin-Producing Escherichia coli Infection and Antibodies against Stx2 and Stx1 in Household Contacts of Children with Enteropathic Hemolytic-Uremic Syndrome. J. Clin. Microbiol. 40: 1773-1782 [Abstract] [Full Text]  
  • Ludwig, K., Karmali, M. A., Sarkim, V., Bobrowski, C., Petric, M., Karch, H., Muller-Wiefel, D. E., Arbeitsgemeinschaft fur Padiatrische Nephrologie, (2001). Antibody Response to Shiga Toxins Stx2 and Stx1 in Children with Enteropathic Hemolytic-Uremic Syndrome. J. Clin. Microbiol. 39: 2272-2279 [Abstract] [Full Text]  
  • Miyazawa, H., Bannai, H., Yanase, T., Morita, C., Satoh, S., Sugiyama, J., Taniguchi, S., Inouye, S. (1999). A Reverse-Sandwich Enzyme-Linked Immunosorbent Assay for Verocytotoxin 1 and 2 Antibodies in Human and Bovine Sera. CVI 6: 701-704 [Abstract] [Full Text]  
  • Menge, C., Wieler, L. H., Schlapp, T., Baljer, G. (1999). Shiga Toxin 1 from Escherichia coli Blocks Activation and Proliferation of Bovine Lymphocyte Subpopulations In Vitro. Infect. Immun. 67: 2209-2217 [Abstract] [Full Text]  
  • Hashimoto, H., Mizukoshi, K., Nishi, M., Kawakita, T., Hasui, S., Kato, Y., Ueno, Y., Takeya, R., Okuda, N., Takeda, T. (1999). Epidemic of Gastrointestinal Tract Infection Including Hemorrhagic Colitis Attributable to Shiga Toxin 1-producing Escherichia coli O118:H2 at a Junior High School in Japan. Pediatrics 103: e2-2 [Abstract] [Full Text]  
  • Louie, M., Read, S., Simor, A. E., Holland, J., Louie, L., Ziebell, K., Brunton, J., Hii, J. (1998). Application of Multiplex PCR for Detection of Non-O157 Verocytotoxin-Producing Escherichia coli in Bloody Stools: Identification of Serogroups O26 and O111. J. Clin. Microbiol. 36: 3375-3377 [Abstract] [Full Text]  
  • Laegreid, W., Hoffman, M., Keen, J., Elder, R., Kwang, J. (1998). Development of a Blocking Enzyme-Linked Immunosorbent Assay for Detection of Serum Antibodies to O157 Antigen of Escherichia coli. CVI 5: 242-246 [Abstract] [Full Text]  
  • Nataro, J. P., Kaper, J. B. (1998). Diarrheagenic Escherichia coli. Clin. Microbiol. Rev. 11: 142-201 [Abstract] [Full Text]